| Released | Contributor | Author | Title | Pages | Price |
|---|
| May 1, 2013 | New Constructs, LLC | N/A | TEVA: Due Diligence Review: Forensic Earnings and Valuation | 13 | $25 | | May 1, 2013 | Stock Traders Daily | Thomas H Kee Jr. | Trading Report for (TEVA). A detailed report, including free correlated market analysis, and updates. | 5 | $57.50 | | May 1, 2013 | ValuEngine, Inc. | N/A | ValuEngine Detailed Valuation Report for TEVA | 11 | $126.50 | | May 1, 2013 | ValuEngine, Inc. | N/A | ValuEngine Industry Report for Medical-generic Drugs | 17 | $195.50 | | Apr 15, 2013 | Stock Traders Daily | Thomas H Kee Jr. | The Investment Rate - a measure of investment demand. | 43 | $494.50 | | Apr 28, 2013 | Market Edge | N/A | Market Edge Equity Research Report | 4 | $10 | | Apr 26, 2013 | Reuters Investment Profile | N/A | Teva Pharmaceutical Industries Ltd: Business description, financial summary, 3yr and interim financials, key statistics/ratios and historical ratio analysis. | 12 | $138 | | Apr 25, 2013 | Ford Investor Services, Inc. | N/A | Industry Value Graph: BAYRY , BMY , LLY , SNY , TEVA -- DRUGS | 3 | $34.50 | | Apr 25, 2013 | Ford Investor Services, Inc. | N/A | Value Graph: TEVA PHARMACEUT -- TEVA | 1 | $11.50 | | Apr 20, 2013 | TheStreet.com Ratings | N/A | TheStreet.com Ratings Stock Report For: TEVA PHARMACEUTICALS | 5 | $10 |
|
View All Reports for TEVA ... |
|
|
0.30(0.79%) 4:04PM EDT